GlassScriptPhysician profile
Tim T Nguyen
NPI 1184720757
$3,736.94
in general payments reported to CMS, 2019-2025
12 companies · $263 in 2025
The $263 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2021: $2,981 · 2022: $125 · 2023: $120 · 2024: $52.05 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $434.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,935.92 | 2019-2025 | Stravix Pl, Grafix, Grafix Pl |
| Angiodynamics, INC. | $171.50 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Zimmer Biomet Holdings, INC. | $142.43 | 2019-2021 | |
| Grt US Holding, INC. | $124.93 | 2022 | |
| Nevro Corp. | $119.78 | 2023 | Senza |
| Bioventus LLC | $81.26 | 2019-2021 | |
| Depuy Synthes Sales INC. | $34.37 | 2024 | |
| Paragon 28, INC. | $33.81 | 2019-2021 | |
| Organogenesis INC. | $31.83 | 2024-2025 | Cygnus Dual |
| Amgen INC. | $27.67 | 2025 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $25.64 | 2025 | Nuzyra |
| Terumo Bct, INC. | $7.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tim Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.